Firm has capacity to make 1bn doses of Oxford University drug undergoing trials
AstraZeneca has said it has the capacity to manufacture 1bn doses of the University of Oxford’s potential Covid-19 vaccine and will begin supply in September if clinical trials are successful.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus breakthrough: Vaccine by September as UK drug-maker receives $1BN from USTHE United States has handed over $1 billion to British drugmaker AstraZeneca Plc to help develop a coronavirus vaccine which could be ready by September.
Read more »
'It so exciting to wake up to good news': Vaccine trial volunteer on potential coronavirus breakthroughWhen Jennifer Haller started trial number of global deaths stood at just 9,000 she tells Andrew Buncombe
Read more »
Leaked Pentagon memo warns coronavirus 'will be globally-persistent' until summer of 2021 without a vaccineCORONAVIRUS “will be globally-persistent” until at least the summer of 2021 without a vaccine, according to a leaked Pentagon memo. The grim forecast said The Defense Department should…
Read more »
Sky News @SkyNewsWatch live: Government holds its daily coronavirus news conference as figures show that almost 40,000 people in England and Wales died with the coronavirus up to 8 May
Read more »
RSPB team home after epic remote island voyageFour Britons were among those stranded on the South Atlantic island amid the coronavirus crisis.
Read more »
Coronavirus: Evening updateFive things you need to know about the coronavirus outbreak this evening.
Read more »